Suffolk has reached a major milestone in the construction of BioMed Realty’s 585 Kendall, a mixed-use building that will house both lab and office space as well as a performing arts center. Located in the Canal District of Kendall Square in Cambridge, MA, Takeda has already leased approximately 600,000 square feet for its global R&D center.
“We are thrilled to mark this significant moment in the development of this complex facility,” stated John Fish, Chairman and CEO of Suffolk. “We would like to thank our partners at BioMed and Takeda for their collaboration throughout this project and their investment not only in our community but also their confidence in Suffolk to deliver such an impactful project for the life sciences industry as well as Cambridge and Massachusetts.”
Expected to be ready for occupancy by 2026, 585 Kendall is designed with the diverse needs of Cambridge residents in mind. In addition to its lab/office space component, it will feature a state-of-the-art performing arts center spanning over 30
